Company Filing History:
Years Active: 2006-2009
Title: Andrew Derrick Gribble: Innovator in Antipsychotic Agents
Introduction
Andrew Derrick Gribble is a notable inventor based in Harlow, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antipsychotic agents. With a total of 2 patents, Gribble's work has the potential to impact therapeutic practices in mental health.
Latest Patents
Gribble's latest patents include innovative compounds such as 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use. This invention provides compounds that are crucial for therapeutic applications. Another significant patent involves sulfonamide derivatives as antipsychotic agents, which outlines compounds of formula (I) that are useful in therapy, particularly for treating psychiatric conditions.
Career Highlights
Gribble is associated with Glaxo Group Limited, a leading company in the pharmaceutical industry. His work at Glaxo has allowed him to focus on developing new therapeutic agents that can improve patient outcomes in mental health.
Collaborations
Gribble has collaborated with notable colleagues such as Ian Thomson Forbes and Andrew Lightfoot. These collaborations have fostered an environment of innovation and have contributed to the advancement of their shared goals in pharmaceutical research.
Conclusion
Andrew Derrick Gribble is a prominent figure in the field of pharmaceuticals, with a focus on antipsychotic agents. His contributions through patents and collaborations highlight his commitment to improving mental health therapies.